Monoclonal antibody combination could offer less toxic acute lymphoblastic leukemia treatment.
Specialty Pharmacy
Advertisement
Outdated measurements of cancer drug response could prevent some patients from receiving beneficial treatments.
Advertisement
Top articles of the week on The American Journal of Pharmacy Benefits.
Top news of the week in oncology, and cancer drug development.
Novel class of antitumor amphiphilic amines causes death in several cancer cell lines.
Creating standard terminology may improve medication safety and efficacy in precision medicine.
Advertisement
Hepatitis B can lead to liver cancer and cirrhosis.
Athletes from a variety of sports dealt with the hardships of diseases treated by specialty pharmacy.
Top news of the day from across the health care landscape.
Access to care improves among post liver transplant patients.
Advertisement
Updated criteria outlined by ASCO may lead to an increase in the number of breast cancers that test HER2-positive.
System would allow for less painful infusions that do not pierce the skin.
Anti-PD-1 antibodies produced more activated antiviral cells to attack HIV.
Top news of the week on Specialty Pharmacy Times.
Manufacturer coupons found to show significant benefits reducing Sovaldi cost share.
HIV screenings at home and immediate administration of antiretroviral therapy in HIV-positive patients shows promise.
Top news of the day from across the health care landscape.
Pediatric Hodgkin lymphoma survivors are twice as likely to develop cardiovascular disease.
It was previously believed that HIV-related brain inflammation may prevent Alzheimer’s disease.
Study offers hope to women for whom infertility treatments were unsuccessful.
ASCL1 protein critical in the development of small cell lung cancer.
A look at the lighter side of pharmacy and the rigors of patient management.
An ideal patient care model in specialty pharmacy involves several factors.
Vyndaqel in development for mild transthyretin familial amyloid polyneuropathy (TTR-FAP).
Olanzapine found to reduce chemotherapy-induced nausea and vomiting in cancer patients.
Glunomab may inhibit the progression of motor disorders associated with multiple sclerosis.
Treatment with Truvada highly effective in reducing the risk of HIV.
Top news of the day from across the health care landscape.
Certain mutations influence risk of drug resistance across several cancer types.
Zepatier is a fixed-dose combination therapy of elbasvir and grazoprevir for chronic hepatitis C.
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
4
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
5